The study found that among the BRCA1 mutation carriers, a risk-reducing mastectomy was associated with a 90% reduction in the risk of developing subsequent breast cancer (incidental cancer) during a median follow-up of 3.6 years [28]. This evidence concerns the gene BRCA1 and breast cancer.